0.05Open0.05Pre Close0 Volume140 Open Interest2.00Strike Price0.00Turnover288.78%IV81.42%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier11DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1949Delta0.4776Gamma22.60Leverage Ratio-0.0069Theta0.0001Rho4.41Eff Leverage0.0006Vega
Pacific Biosciences of California Stock Discussion
PacBio Announces Plans to Improve Methylation Detection in HiFi Chemistry
Monday, 28th April at 9:05 am
MENLO PARK, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced it plans to improve on its already highly accurate methylation detection capabilities in HiFi chemistry through licensing advanced DNA methylation detection methods developed by P...
PacBio's sequencing technology will power the first North African dementia registry, addressing critical gaps in Alzheimer's genetic research.
This collaboration addresses a significant blindspot in Alzheimer's research by focusing on the understudied genetic landscape of North African populations. The North African Dementia Registry (NADR) marks the first dementia-focused registry of its kind in the region, creating a founda...
PacBio gains scientific validation through Alzheimer's research partnership in understudied North African populations, expanding application potential.
This partnership with the Davos Alzheimer's Collaborative (DAC) represents strategic positioning for PacBio in the emerging field of neurogenomics. The company's long-read sequencing technology offers distinct advantages for studying complex genetic factors in Alzheimer's disease ...
Groundbreaking 110M-Population Alzheimer's Study Launches in North Africa: PacBio Leads Genetic Research
Davos Alzheimer's Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer's Disease Research in North Africa
Tuesday, 22nd April at 9:04 am
MENLO PARK, Calif. and GENEVA, Switzerland , April 22, 2025 (GLOBE NEWSWIRE) -- The Davos Alzheimer's Collaborative (DAC), a global initiative to prevent Alzheimer's disease and improve brain health, today announced that PacBio (NASDAQ: PACB), a leader in high-quality, highly...
PacBio's Bold Move: $50M Cost Cut Plan as Q1 Shows Record Consumables Growth
where will it go? how far higher
No comment yet